Results 121 to 130 of about 843,559 (297)

Studies on the production, characterisation and applications of monoclonal antibodies and antibody-based conjugates [PDF]

open access: yes, 1994
The work described in this thesis involved the production of antibodies to several defined antigens and the chemical synthesis of bispecific antibodies. Monoclonal antibodies against glial fibrillary acidic protein (anti-GFAP), and against a GFAP-like
Cahill, Dolores J.
core   +2 more sources

Real‐World Effectiveness of Tildrakizumab in Biologic‐Naive Plaque Psoriasis: A Case Series

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Tildrakizumab is a selective interleukin‐23 p19 inhibitor approved for moderate‐to‐severe plaque psoriasis. Real‐world data, specifically in biologic‐naive patients, remains limited. Objectives To evaluate the real‐world effectiveness and safety of tildrakizumab 100 mg in biologic‐naive patients with moderate‐to‐severe plaque ...
Davindra Singh   +2 more
wiley   +1 more source

Real World Use of the IL‐36 Receptor Antagonist Spesolimab: A Systematic Review and Analysis

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Spesolimab, an interleukin‐36 receptor antagonist, is approved for the treatment and prevention of generalised pustular psoriasis (GPP) flares. Its use has increasingly been reported in real‐world settings for both GPP and other inflammatory dermatoses.
Sophia A. Mense   +4 more
wiley   +1 more source

Recent Advances (2023–2025) of Capillary Electrophoresis‐Mass Spectrometry (CE‐MS) for Top‐Down Proteomics

open access: yesMass Spectrometry Reviews, EarlyView.
ABSTRACT Top‐down proteomics (TDP) characterizes proteoforms in cells, tissues, and biofluids, in discovery mode and on a global scale, requiring analytical tools with high peak capacity for proteoform separation and high sensitivity for proteoform detection, given the extremely high proteoform complexity and wide proteoform concentration dynamic range.
Guijie Zhu   +5 more
wiley   +1 more source

Sensitivity test of monoclonal antibodies Streptococcus mutans 1(c) 67 kDa [PDF]

open access: yes, 2010
Background: Based on SKRT 2004, dental caries prevalence rate in Indonesia reached 90,05%. Local passive immunization with monoclonal antibodies is a new alternative in caries prevention.
Indah Listiana Kriswandini   +2 more
core   +1 more source

APPLICATION OF GENE ENGINEERING IN THE TREATMENT OF PATIENTS WITH COVID-19

open access: yesМедична наука України
Background. Modern therapeutic options for the treatment of COVID-19 combine the use of drugs that affect both the virus itself and the components of the body's immune response.
V.D. Moskaliuk   +3 more
doaj   +1 more source

Analysis of Carbohydrates and Glycoconjugates by Matrix‐Assisted Laser Desorption/Ionization Mass Spectrometry: An Update for 2023–2024

open access: yesMass Spectrometry Reviews, EarlyView.
ABSTRACT The use of MALDI mass spectrometry for the analysis of carbohydrates and glycoconjugates is a well‐established technique and this comprehensive review is the twelfth update of the original article published in 1999 and brings coverage of the literature to the end of 2024.
David J. Harvey
wiley   +1 more source

SERPINB9 Promotes Colorectal Cancer Liver Metastasis and Immunotherapy Resistance: Association With MHC‐I Downregulation and CD8+ T Cell Dysfunction

open access: yesMedicine Bulletin, EarlyView.
ABSTRACT Background Colorectal cancer liver metastasis (CRLM) is the leading cause of mortality in colorectal cancer (CRC) patients, for which effective treatments remain limited. The mechanisms by which tumor cells evade immune surveillance and escape cytotoxic killing remain poorly understood.
Xin Liu   +4 more
wiley   +1 more source

Passive immunotherapy for Alzheimer’s disease: challenges & future directions

open access: yesJournal of Translational Medicine
Passive immunotherapy with specific antibodies targeting Amyloid β (Aβ) peptide or tubulin-associated unit (tau) protein has emerged as a promising therapeutic approach in Alzheimer’s disease (AD).
Ling Xiao Yi   +2 more
doaj   +1 more source

TGF‐β Inhibition Attenuates Tau Accumulation and Neurodegeneration in Progressive Supranuclear Palsy Patient‐Derived Organoids

open access: yesMovement Disorders, EarlyView.
Abstract Background Progressive supranuclear palsy (PSP) is a devastating 4‐repeat tauopathy with no approved disease‐modifying treatments. Recent evidence showed increased transforming growth factor‐β (TGF‐β) levels in PSP patient‐derived ventral midbrain organoids (vMOs) and serum neuronally derived exosomes. Objective This study investigated whether
Mariagrazia Talarico   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy